Globus Medical (GMED) Tops Q1 EPS by 5c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Globus Medical Reports First Quarter 2018 Results
May 2, 2018 4:15 PM EDTAUDUBON, Pa., May 02, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the first quarter ended March 31, 2018.
Worldwide sales were $174.4 million, an increase of 11.9% as reported, or 10.8% in constant currencyFirst quarter net income was $39.5 million, or 22.7% of salesDiluted earnings per share (EPS) were $0.39Non-GAAP diluted EPS were $0.41Non-GAAP adjusted EBITDA was 35.4% of salesWe had a strong first quarter with worldwide sales up 11.9% over the first quarter of 2017 at $174... More
